The Filings Report

BioMarin Pharmaceuticals Inc insider trading

BMRNfinancial statementsForm 4 filings on EDGAR97 transactions since Nov 9, 2024

From August 12, 2026 to November 9, 2026, 0 insiders at BioMarin Pharmaceuticals Inc bought $0 of stock in the open market, and 1 sold $1M. Officers and directors accounted for $0 of purchases and $1M of sales. The last reported transaction was a tax withholding by Friberg Gregory R on September 30, 2026.

The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 1, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.

Stock price and insider activity

Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.

BMRN daily priceSplit-adjusted prices in US dollars

Bought $0Sold $1MAug 12, 2026 – Nov 9, 2026

Nov 9, 2026O $56.56 · H $57.45 · L $54.71 · C $57.18Bought $0 (0)Sold $0 (0)
$51$56$61$67$722026-08-12: open $68.71, high $70.98, low $68.43, close $70.242026-08-13: open $70.35, high $70.35, low $68.36, close $68.532026-08-14: open $68.53, high $68.53, low $67.12, close $67.362026-08-17: open $67.00, high $67.63, low $66.21, close $66.642026-08-18: open $67.21, high $68.27, low $66.84, close $66.992026-08-19: open $68.17, high $69.62, low $67.75, close $69.332026-08-20: open $68.11, high $68.75, low $67.57, close $67.682026-08-21: open $67.55, high $68.34, low $66.52, close $66.702026-08-24: open $66.57, high $67.18, low $64.71, close $65.072026-08-25: open $65.03, high $66.36, low $65.02, close $66.122026-08-26: open $65.62, high $66.53, low $65.33, close $65.612026-08-27: open $65.28, high $65.92, low $64.83, close $65.292026-08-28: open $64.99, high $65.08, low $64.07, close $64.672026-08-31: open $65.95, high $66.30, low $64.33, close $65.232026-09-01: open $65.54, high $66.02, low $64.49, close $64.842026-09-02: open $65.00, high $67.20, low $64.99, close $66.972026-09-03: open $67.30, high $67.70, low $66.32, close $66.432026-09-04: open $65.79, high $66.64, low $65.52, close $66.532026-09-08: open $65.24, high $66.26, low $64.01, close $64.632026-09-09: open $63.83, high $65.33, low $63.64, close $64.412026-09-10: open $64.41, high $65.59, low $63.57, close $65.512026-09-11: open $65.96, high $66.05, low $65.29, close $65.682026-09-14: open $66.27, high $66.88, low $65.72, close $66.412026-09-15: open $65.78, high $65.78, low $63.85, close $64.452026-09-16: open $64.48, high $65.67, low $64.34, close $64.732026-09-17: open $65.34, high $66.21, low $64.97, close $65.082026-09-18: open $65.25, high $65.29, low $63.89, close $63.942026-09-21: open $64.35, high $64.96, low $63.58, close $64.062026-09-22: open $64.34, high $64.79, low $63.35, close $63.372026-09-23: open $63.68, high $64.00, low $61.58, close $62.212026-09-24: open $62.21, high $62.33, low $61.13, close $61.352026-09-25: open $61.50, high $61.50, low $60.17, close $60.262026-09-28: open $59.87, high $60.07, low $58.74, close $59.462026-09-29: open $59.24, high $60.09, low $58.96, close $59.872026-09-30: open $59.90, high $60.71, low $59.37, close $60.002026-10-01: open $59.81, high $60.16, low $58.39, close $58.442026-10-02: open $58.52, high $58.73, low $57.15, close $57.182026-10-05: open $57.11, high $58.11, low $56.82, close $57.542026-10-06: open $57.54, high $57.88, low $55.76, close $56.222026-10-07: open $56.05, high $56.30, low $54.76, close $55.202026-10-08: open $54.95, high $54.97, low $53.90, close $54.892026-10-09: open $54.80, high $55.98, low $54.48, close $54.802026-10-12: open $55.56, high $55.96, low $54.90, close $55.392026-10-13: open $55.30, high $55.66, low $53.93, close $54.382026-10-14: open $54.75, high $55.56, low $54.46, close $55.142026-10-15: open $56.45, high $57.59, low $55.96, close $56.052026-10-16: open $56.32, high $56.53, low $54.44, close $54.682026-10-19: open $54.78, high $55.12, low $54.08, close $54.672026-10-20: open $55.08, high $56.48, low $54.95, close $56.442026-10-21: open $56.40, high $57.00, low $54.91, close $55.212026-10-22: open $55.40, high $56.91, low $55.02, close $56.632026-10-23: open $56.68, high $56.81, low $55.24, close $55.952026-10-26: open $56.50, high $56.89, low $55.34, close $55.752026-10-27: open $55.83, high $56.09, low $55.05, close $55.352026-10-28: open $55.18, high $56.18, low $54.85, close $56.002026-10-29: open $56.58, high $57.51, low $56.29, close $57.492026-10-30: open $58.40, high $59.37, low $57.86, close $58.512026-11-02: open $58.66, high $59.51, low $57.17, close $57.442026-11-03: open $53.06, high $56.33, low $52.00, close $55.662026-11-04: open $56.60, high $57.51, low $55.67, close $57.132026-11-05: open $57.44, high $57.99, low $55.97, close $56.122026-11-06: open $55.25, high $56.08, low $55.00, close $56.032026-11-09: open $56.56, high $57.45, low $54.71, close $57.18Insider purchases / sales · USD$2M$0−$2M2026-09-02: 0 purchases ($0), 1 sales ($1M)Aug 12Sep 3Sep 25Oct 19Nov 9

purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.

Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 9, 2026. Insider data through Nov 9, 2026. Prices are adjusted for splits; transaction values are reported dollars.

Every transaction

97 transactions from November 9, 2024 to November 9, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Sep 30, 2026Friberg Gregory REVP, Chief R&D Officertax withholding4,086$60.00$245K47,732Oct 1, 2026
Sep 10, 2026Plenge Robert MDirectoraward6,140$0.00—6,140Sep 14, 2026
Sep 2, 2026Davis George EricEVP, Chief Legal Officeropen-market sale17,557$66.28$1M61,003Sep 3, 2026
Jun 2, 2026Countouriotis AthenaDirectoraward7,490$0.00—21,040Jun 4, 2026
Jun 2, 2026Walbert Timothy PDirectoraward7,490$0.00—17,270Jun 4, 2026
Jun 2, 2026Ho MaykinDirectoraward7,490$0.00—35,500Jun 4, 2026
Jun 2, 2026Hombach Robert J.Directoraward7,490$0.00—49,360Jun 4, 2026
Jun 2, 2026Enyedy Mark JDirectoraward7,490$0.00—21,040Jun 4, 2026
Jun 2, 2026Dere Willard HDirectoraward7,490$0.00—46,440Jun 4, 2026
Jun 2, 2026Clark Ian TDirectoraward7,490$0.00—14,490Jun 4, 2026
Jun 2, 2026Bodem Barbara W.Directoraward7,490$0.00—21,045Jun 4, 2026
Jun 2, 2026Anderson Elizabeth MDirectoraward7,490$0.00—41,940Jun 4, 2026
May 20, 2026Hubbard CristinEVP, Chief Commercial Officertax withholding2,318$50.20$116K42,472May 21, 2026
May 7, 2026Friberg Gregory REVP, Chief R&D Officeropen-market sale3,281$53.85$177K51,818May 11, 2026
Mar 18, 2026Davis George EricEVP, Chief Legal Officertax withholding1,273$56.05$71K78,560Mar 19, 2026
Mar 17, 2026Guyer Charles GregEVP, Chief Technical Officertax withholding1,693$56.05$95K84,140Mar 19, 2026
Mar 17, 2026Mueller BrianEVP, Chief Financial Officertax withholding2,117$56.05$119K123,314Mar 19, 2026
Mar 17, 2026Hardy AlexanderChief Executive Officer, Directortax withholding4,252$56.05$238K214,635Mar 19, 2026
Mar 17, 2026Hubbard CristinEVP, Chief Commercial Officertax withholding1,245$56.05$70K44,790Mar 18, 2026
Mar 17, 2026Friberg Gregory REVP, Chief R&D Officertax withholding1,629$56.05$91K55,099Mar 18, 2026
Mar 16, 2026Hubbard CristinEVP, Chief Commercial Officeraward15,410$0.00—46,035Mar 18, 2026
Mar 16, 2026Friberg Gregory REVP, Chief R&D Officeraward19,150$0.00—56,728Mar 18, 2026
Mar 16, 2026Guyer Charles GregEVP, Chief Technical Officeraward14,990$0.00—85,833Mar 17, 2026
Mar 16, 2026Davis George EricEVP, Chief Legal Officeraward14,570$0.00—79,833Mar 17, 2026
Mar 16, 2026Davis George EricEVP, Chief Legal Officertax withholding7,177$58.51$420K65,263Mar 17, 2026
Mar 16, 2026Mueller BrianEVP, Chief Financial Officeraward18,740$0.00—125,431Mar 17, 2026
Mar 16, 2026Hardy AlexanderChief Executive Officer, Directoraward62,440$0.00—218,887Mar 17, 2026
Mar 13, 2026Guyer Charles GregEVP, Chief Technical Officertax withholding9,109$58.51$533K70,843Mar 17, 2026
Mar 13, 2026Mueller BrianEVP, Chief Financial Officertax withholding9,945$58.51$582K106,691Mar 17, 2026
Mar 13, 2026Hardy AlexanderChief Executive Officer, Directortax withholding2,941$58.51$172K156,447Mar 17, 2026
Mar 11, 2026Guyer Charles GregEVP, Chief Technical Officeropen-market sale16,486$60.46$997K79,953Mar 12, 2026
Feb 26, 2026Friberg Gregory REVP, Chief R&D Officeropen-market sale6,326$60.38$382K37,578Feb 26, 2026
Feb 26, 2026Davis George EricEVP, Chief Legal Officeropen-market sale26,061$61.36$2M72,453Feb 26, 2026
Feb 25, 2026Guyer Charles GregEVP, Chief Technical Officeraward2,371$0.00—96,439Feb 26, 2026
Feb 25, 2026Guyer Charles GregEVP, Chief Technical Officeraward6,675$0.00—94,068Feb 26, 2026
Feb 25, 2026Guyer Charles GregEVP, Chief Technical Officeraward6,176$0.00—87,393Feb 26, 2026
Feb 25, 2026Davis George EricEVP, Chief Legal Officeraward2,372$0.00—98,514Feb 26, 2026
Feb 25, 2026Davis George EricEVP, Chief Legal Officeraward6,675$0.00—96,142Feb 26, 2026
Feb 25, 2026Davis George EricEVP, Chief Legal Officeraward6,177$0.00—89,467Feb 26, 2026
Feb 25, 2026Mueller BrianEVP, Chief Financial Officeraward2,569$0.00—116,638Feb 26, 2026
Feb 25, 2026Mueller BrianEVP, Chief Financial Officeraward7,230$0.00—114,069Feb 26, 2026
Feb 25, 2026Mueller BrianEVP, Chief Financial Officeraward6,683$0.00—106,839Feb 26, 2026
Jan 20, 2026Ramchandani Rashmi VirendraVP, Chief Accounting Officeraward18,540$0.00—18,540Jan 22, 2026
Jan 20, 2026Ramchandani Rashmi VirendraVP, Chief Accounting Officeraward7,070$0.00—25,610Jan 22, 2026
Dec 30, 2025Meier Richard ADirectorgift500$0.00—126,926Feb 13, 2026
Dec 1, 2025Hardy AlexanderChief Executive Officer, Directortax withholding16,570$55.03$912K159,388Dec 2, 2025
Oct 31, 2025Hubbard CristinEVP, Chief Commercial Officeraward80$45.54$4K30,625Feb 13, 2026
Oct 31, 2025Guyer Charles GregEVP, Chief Technical Officeraward62$45.54$3K81,217Feb 13, 2026
Oct 31, 2025Friberg Gregory REVP, Chief R&D Officeraward398$45.54$18K43,904Feb 13, 2026
Sep 30, 2025Friberg Gregory REVP, Chief R&D Officertax withholding3,304$54.16$179K43,506Oct 2, 2025

Who the insiders are

Everyone who reported a transaction since November 9, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.

InsiderRoleLast transactionKindShares heldBought, 12 monthsSold, 12 monthsSales under a plan
Davis George EricEVP, Chief Legal OfficerSep 2, 2026open-market sale61,003—$3M (2)0 of 2
Guyer Charles GregEVP, Chief Technical OfficerMar 17, 2026tax withholding84,140—$997K (1)0 of 1
Friberg Gregory REVP, Chief R&D OfficerSep 30, 2026tax withholding47,732—$559K (2)0 of 2
Mueller BrianEVP, Chief Financial OfficerMar 17, 2026tax withholding123,314———
Hubbard CristinEVP, Chief Commercial OfficerMay 20, 2026tax withholding42,472———
Hardy AlexanderChief Executive Officer, DirectorMar 17, 2026tax withholding214,635———
Burkhart ErinGVP, Chief Accounting OfficerMay 20, 2025open-market sale14,173———
Walbert Timothy PDirectorJun 2, 2026award17,270———
Countouriotis AthenaDirectorJun 2, 2026award21,040———
Ho MaykinDirectorJun 2, 2026award35,500———
Hombach Robert J.DirectorJun 2, 2026award49,360———
Enyedy Mark JDirectorJun 2, 2026award21,040———
Dere Willard HDirectorJun 2, 2026award46,440———
Clark Ian TDirectorJun 2, 2026award14,490———
Bodem Barbara W.DirectorJun 2, 2026award21,045———
Anderson Elizabeth MDirectorJun 2, 2026award41,940———
Ramchandani Rashmi VirendraVP, Chief Accounting OfficerJan 20, 2026award18,540———
Meier Richard ADirectorDec 30, 2025gift126,926———
Plenge Robert MDirectorSep 10, 2026award6,140———

Questions

Are BioMarin Pharmaceuticals Inc insiders buying or selling?

Over the twelve months to November 9, 2026, 3 insiders at BioMarin Pharmaceuticals Inc sold $4M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $4M. Only open-market purchases and sales are counted.

Who sold the most BioMarin Pharmaceuticals Inc stock in the last year?

Davis George Eric (EVP, Chief Legal Officer) sold $3M in 2 open-market sales over the twelve months to November 9, 2026.

Do BioMarin Pharmaceuticals Inc executives sell under 10b5-1 plans?

0 of the 5 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.

What counts as insider buying here?

Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.

More on BioMarin Pharmaceuticals Inc

From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.